CN1062141C - Potent pearl eye drops - Google Patents

Potent pearl eye drops Download PDF

Info

Publication number
CN1062141C
CN1062141C CN94111435A CN94111435A CN1062141C CN 1062141 C CN1062141 C CN 1062141C CN 94111435 A CN94111435 A CN 94111435A CN 94111435 A CN94111435 A CN 94111435A CN 1062141 C CN1062141 C CN 1062141C
Authority
CN
China
Prior art keywords
pearl
present
eye drop
eye drops
leech
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94111435A
Other languages
Chinese (zh)
Other versions
CN1112435A (en
Inventor
门摩西
蒋冰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING ENVIRONMENTAL SCIENCE INST STATE ENVIRONMENTAL PROTECTION BUREAU
Original Assignee
NANJING ENVIRONMENTAL SCIENCE INST STATE ENVIRONMENTAL PROTECTION BUREAU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING ENVIRONMENTAL SCIENCE INST STATE ENVIRONMENTAL PROTECTION BUREAU filed Critical NANJING ENVIRONMENTAL SCIENCE INST STATE ENVIRONMENTAL PROTECTION BUREAU
Priority to CN94111435A priority Critical patent/CN1062141C/en
Publication of CN1112435A publication Critical patent/CN1112435A/en
Application granted granted Critical
Publication of CN1062141C publication Critical patent/CN1062141C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention proposes a pearl eye drop which belongs to the technical field of medicines. The pearl eye drop comprises 88 to 97 % of pearl hydrolysate, 0.5 to 3.3% of red leech hydrolysate, 0.2 to 1.8% of plum blossom, 0.5 to 3.3% of mint, 0.5 to 1.5% of boric acid, 0.3 to 0.9% of sodium chloride, 0.01 to 0.1% of nipagin, 0.1 to 1% of polyvinylpyrrolidone (K30) according to component compounding quantity and is prepared by the process flow of leech, pearl and mint extraction, mixing, pH value adjustment and osmotic pressure and filtration. The present invention has obvious therapeutic effect on senile cataract and vision improvement. Ocular tension can be reduced within 15 mintues. The present invention is an ideally eye drop.

Description

Pearl eye drops
What the present invention proposed is a kind of pearl eye drops, belongs to field of pharmaceutical technology.
Prior art is as the ZHENZHU MINGMUYE of production and sales in the market.Its composition also has Margarita water medium liquid etc.But shy sense is arranged after it uses, and it is slower to take effect, not obvious.And it only acts on eye surface, and its physical and chemical index changes with the change of temperature and surrounding.
The objective of the invention is to effectively overcome the defective of above-mentioned existence, therapeutic effect is remarkable.Refrigerant, comfortable, moisture feeling are arranged after the use immediately.
Technical solution of the present invention: its proportioning components: Margarita water medium liquid 88-97%, Hirudo water medium liquid 0.5-3.3%, borneol 0.2-1.8%, Herba Menthae extracting solution 0.5-3.3%, boric acid 0.5-1.5%, sodium chloride 0.3-0.9%, nipalgin 0.01-0.1%, polyethylene pyrrolinone (K30) 0.1-1.0%; (unit of weight).Its technological process is that (1) each composition is got ready in the proportioning ratio, (2) under 110 ℃ of temperature, carry out Hirudo water Jie, Margarita water Jie, Herba Menthae extraction, time is 24-48 hour, (3) all compositions are mixed vibration and stir 24 hours (room temperature), (4) add micro-antiseptic, (5) (being suitable for eye uses to regulate pH value, 4.5-7.5PH value), (6) regulate osmotic pressure and reach the human body fluid unanimity, meet the medicine inspection standard, (7) Filtration commonly used filters clear and bright, (8) quality inspection, (9) filling and package, (10) product inspection.
Embodiment:adopt following three embodiment of process choice of the present invention to be described. proportioning components (example 1) proportioning (example 2) proportioning (example 3) pearl water medium liquid 0.97 0.91 0.88 leech water medium liquid 0.005 0.001 0.033 Borneolum 0.002 0.025 0.018 peppermint 0.005 0.015 0.033 boric acid 0.005 0.009 0.015 sodium chloride 0.003 0.006 0.009 nipalgin, 0.0001 0.00055 0.001 PVPs (K3O) 0.001 0.0055 0.01
(unit of weight)
Through clinic trial. the control to senile cataract reaches 92%, improves vision 〉=80%, uses to reduce intraocular pressure in 15 minutes and reach %%.Use the back eyes to produce refrigerant, comfortable, moisture feeling immediately in addition, eyes become clear, it is clear to look thing.Use the present invention pleasing to the eye → cornea → conjunctiva → aqueous humor → iris → crystalline lens and vitreous body → retina choroid.It is not only eye surface.The physical and chemical index of product does not become with temperature and surrounding.5 years effect duration.

Claims (1)

1, pearl eye drops, it is characterized in that by the composition of following percentage by weight formulated: Margarita water medium liquid 88-97%, Hirudo water medium liquid 0.5-3.3%, borneol 0.2-1.8%, Herba Menthae extracting solution 0.5-3.3%, boric acid 0.5-1.5%, sodium chloride 0.3-0.9%, nipalgin 0.01-0.1%, polyethylene pyrrolinone K30 is 0.1-1.0%; Carry out Hirudo water Jie, Margarita water Jie, Herba Menthae extraction under 110 ℃ of temperature, the time is 24-48 hour.
CN94111435A 1994-09-10 1994-09-10 Potent pearl eye drops Expired - Fee Related CN1062141C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94111435A CN1062141C (en) 1994-09-10 1994-09-10 Potent pearl eye drops

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94111435A CN1062141C (en) 1994-09-10 1994-09-10 Potent pearl eye drops

Publications (2)

Publication Number Publication Date
CN1112435A CN1112435A (en) 1995-11-29
CN1062141C true CN1062141C (en) 2001-02-21

Family

ID=5035303

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94111435A Expired - Fee Related CN1062141C (en) 1994-09-10 1994-09-10 Potent pearl eye drops

Country Status (1)

Country Link
CN (1) CN1062141C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100423731C (en) * 2004-01-01 2008-10-08 北海国发海洋生物产业股份有限公司 Eye brightening eye washing liquid and its preparation method
CN101549067B (en) * 2009-04-13 2011-11-02 俞寿良 Chinese medicinal composition and uses thereof
RU2526826C2 (en) 2012-10-24 2014-08-27 Николай Владимирович Соловьёв Parenteral composition, method for preparing and using composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033154A (en) * 1987-11-20 1989-05-31 李际云 A kind of collyrium
CN1076113A (en) * 1992-03-11 1993-09-15 贺茂麟 A kind of collyrium and preparation thereof
CN1088813A (en) * 1993-01-01 1994-07-06 程俊芬 " Kanghongyi " antiflammatory eyedrops

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033154A (en) * 1987-11-20 1989-05-31 李际云 A kind of collyrium
CN1076113A (en) * 1992-03-11 1993-09-15 贺茂麟 A kind of collyrium and preparation thereof
CN1088813A (en) * 1993-01-01 1994-07-06 程俊芬 " Kanghongyi " antiflammatory eyedrops

Also Published As

Publication number Publication date
CN1112435A (en) 1995-11-29

Similar Documents

Publication Publication Date Title
CN101803646A (en) Fat-reducing health protecting tea and preparation method thereof
CN1062141C (en) Potent pearl eye drops
CN102357196B (en) External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof
CN101099589A (en) Health care beverage for eyesight
IE852942L (en) Aqueous formulation of sodium cromoglycate
CN100388923C (en) Chinese-medicinal preparation and making method for treating acute corneitis and releasing visual fatigue
TW427913B (en) Eye drop composition comprising pilocarpine and a β-blocking agent and process making the same
CN1011118B (en) Eyedrops for cataract and their preparation
CN112022938A (en) Hydrogel eye patch for relieving asthenopia and preventing myopia and preparation method thereof
CN108261390A (en) A kind of brinzolamide Brimonidine eye drops and preparation method thereof
CN102441001A (en) Compound allantoin vitamin B6-E and ammoniation ethyl sulfate eye drops and preparation method thereof
CN1045382C (en) Runshu eye drops and making method thereof
CN105168237A (en) Compound gel moisturizing eye drops
CN101897896B (en) Chinese medicinal composition for treating cataract and medicinal preparation and preparation method thereof
CN105983006A (en) Composition for relieving visual fatigue and preparation method of composition
CN105726697B (en) Anti-asthenopia rose composition, eye drop and preparation method of eye drop
JPH10218760A (en) Eye drop with small amount of oil added for treating dry eye
Jain et al. Steroid pentetration in human aqueous with′ Sauflon 70′ lenses
DE19539532C2 (en) Ophthalmic cromoglicate gel preparation
CN107375206A (en) A kind of high biocidal property pearl eyesight improvement drops
CN114146108A (en) Formula of eye drop and preparation method thereof
CN114469900B (en) Pharmaceutical composition for improving eye symptoms, preparation method and use method
CN1047523C (en) Nearsight prevention eye drop solution
CN100540049C (en) Fibre connexin active tears and production method thereof
CN1459291A (en) Eyedrops containing low molecular weight heparin, and its prepn. method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee